70,000+ Minor Men Vaccinated Against HPV in 2022 – Levante-EMV
HPV Vaccination Efforts and Impact
Published: 2025-03-26
Since 2022, more than 70,000 young men have received teh human papillomavirus (HPV) vaccine. Health officials emphasize the importance of vaccination, noting that about 80% of the population will be infected with HPV at some point in thier lives.
One health expert stated, Vaccinating against the human papillomavirus is to invest in health.
Data indicates that HPV prevalence exceeds 90% among young women. In Almeria, more than 90% of young people have been vaccinated against HPV.
The Centers for Disease Control and Prevention (CDC) recommends a two-dose schedule for adolescents starting the HPV vaccine series before age 15. The second dose should be administered 6 to 12 months after the first.If the two doses are given less than 5 months apart, a third dose is required. A three-dose series is recommended for those who start the series between the ages of 15 and 26, and for individuals with compromised immune systems.
The 9-valent HPV vaccine protects against the most common HPV types, which cause 90% of cervical, vaginal, and vulvar cancers, according to the American Academy of Family Physicians.
Research suggests that HPV vaccines are effective against oral HPV infections. Further studies are underway to determine if HPV vaccination can prevent HPV-related oropharyngeal cancers.
HPV vaccination: Your Questions Answered
Published: 2025-03-26
What is HPV and Why is Vaccination Vital?
Human Papillomavirus (HPV) is a common virus, with approximately 80% of the population expected to be infected at some point in their lives. One health expert stated, “Vaccinating against the human papillomavirus is to invest in health.”
What Cancers Does the HPV Vaccine Protect against?
The 9-valent HPV vaccine protects against the most common HPV types, which cause 90% of cervical, vaginal, and vulvar cancers, according to the American Academy of Family Physicians.
Who Should Get the HPV Vaccine and When?
The CDC recommends the HPV vaccine for adolescents.
- A two-dose schedule is recommended for adolescents starting the HPV vaccine series before age 15. The second dose should be administered 6 to 12 months after the first.
- If the two doses are given less than 5 months apart, a third dose is required.
- A three-dose series is recommended for those who start the series between the ages of 15 and 26, and for individuals with compromised immune systems.
How Effective is the HPV Vaccine?
Data indicates that HPV prevalence exceeds 90% among young women.Research suggests that HPV vaccines are effective against oral HPV infections. Further studies are underway to determine if HPV vaccination can prevent HPV-related oropharyngeal cancers.
HPV Vaccination Coverage: What Does the Data Show?
In Almeria, more than 90% of young people have been vaccinated against HPV. As of 2022, more than 70,000 young men have received the HPV vaccine.
HPV Vaccine Schedule summary
The following table summarizes the recommended HPV vaccination schedule.
| Age at Vaccination Start | Dose Schedule |
|---|---|
| Before Age 15 | Two doses, 6-12 months apart |
| Ages 15-26 | Three doses |
| Individuals with compromised immune systems | Three doses |